Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Candida albicans cholecystitis with associated hepatitis in a cat.

Palermo SM, Newman AW, Koch MW.

JFMS Open Rep. 2019 Jun 12;5(1):2055116919854165. doi: 10.1177/2055116919854165. eCollection 2019 Jan-Jun.

2.

Domperidone-induced elevation of serum prolactin levels and immune response in multiple sclerosis.

Koch MW, Liu WQ, Camara-Lemarroy C, Zhang Y, Pike GB, Metz L, Yong VW.

J Neuroimmunol. 2019 May 29;334:576974. doi: 10.1016/j.jneuroim.2019.576974. [Epub ahead of print]

PMID:
31174092
3.

Clinical Reasoning: A pregnant woman with chin numbness.

Arnold AJ, Gilmour GS, Koch MW.

Neurology. 2019 Feb 26;92(9):e996-e999. doi: 10.1212/WNL.0000000000007014. No abstract available.

PMID:
30804068
4.

Genetic characterization of measles virus genotype D6 subacute sclerosing panencephalitis case, Alberta, Canada.

Pabbaraju K, Fonseca K, Wong S, Koch MW, Joseph JT, Tipples GA, Tellier R.

J Neurovirol. 2018 Dec;24(6):720-729. doi: 10.1007/s13365-018-0668-7. Epub 2018 Oct 5.

PMID:
30291564
5.

Global transcriptome profiling of mild relapsing-remitting versus primary progressive multiple sclerosis.

Koch MW, Ilnytskyy Y, Golubov A, Metz LM, Yong VW, Kovalchuk O.

Eur J Neurol. 2018 Apr;25(4):651-658. doi: 10.1111/ene.13565. Epub 2018 Feb 13.

PMID:
29316044
6.

Comparative utility of disability progression measures in PPMS: Analysis of the PROMiSe data set.

Koch MW, Cutter GR, Giovannoni G, Uitdehaag BMJ, Wolinsky JS, Davis MD, Steinerman JR, Knappertz V.

Neurol Neuroimmunol Neuroinflamm. 2017 May 10;4(4):e358. doi: 10.1212/NXI.0000000000000358. eCollection 2017 Jul.

7.

Smoking does not influence disability accumulation in primary progressive multiple sclerosis.

Javizian O, Metz LM, Deighton S, Koch MW.

Eur J Neurol. 2017 Apr;24(4):624-630. doi: 10.1111/ene.13262. Epub 2017 Feb 26.

PMID:
28239937
8.

Subacute sclerosing panencephalitis in pregnancy.

Chiu MH, Meatherall B, Nikolic A, Cannon K, Fonseca K, Joseph JT, MacDonald J, Pabbaraju K, Tellier R, Wong S, Koch MW.

Lancet Infect Dis. 2016 Mar;16(3):366-75. doi: 10.1016/S1473-3099(15)00524-1. Epub 2016 Jan 20. Review.

PMID:
26809815
9.

Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis.

Koch MW, Zabad R, Giuliani F, Hader W Jr, Lewkonia R, Metz L, Wee Yong V.

J Neurol Sci. 2015 Nov 15;358(1-2):131-7. doi: 10.1016/j.jns.2015.08.1525. Epub 2015 Aug 28.

PMID:
26344560
10.

Long-term persistence with injectable therapy in relapsing-remitting multiple sclerosis: an 18-year observational cohort study.

Zhornitsky S, Greenfield J, Koch MW, Patten SB, Harris C, Wall W, Alikhani K, Burton J, Busche K, Costello F, Davenport JW, Jarvis SE, Lavarato D, Parpal H, Patry DG, Yeung M, Metz LM.

PLoS One. 2015 Apr 13;10(4):e0123824. doi: 10.1371/journal.pone.0123824. eCollection 2015.

11.

The promise of futility trials in neurological diseases.

Koch MW, Korngut L, Patry DG, Agha-Khani Y, White C, Sarna JR, Yeung M, Yong VW, Heng DY, Cutter G, Metz L.

Nat Rev Neurol. 2015 May;11(5):300-5. doi: 10.1038/nrneurol.2015.34. Epub 2015 Mar 17. Review.

PMID:
25776824
12.

Serum NSE level and disability progression in multiple sclerosis.

Koch MW, George S, Wall W, Wee Yong V, Metz LM.

J Neurol Sci. 2015 Mar 15;350(1-2):46-50. doi: 10.1016/j.jns.2015.02.009. Epub 2015 Feb 11.

PMID:
25686504
13.

The natural history of early versus late disability accumulation in primary progressive MS.

Koch MW, Greenfield J, Javizian O, Deighton S, Wall W, Metz LM.

J Neurol Neurosurg Psychiatry. 2015 Jun;86(6):615-21. doi: 10.1136/jnnp-2014-307948. Epub 2014 Aug 4.

PMID:
25091366
14.

Depression in multiple sclerosis: a long-term longitudinal study.

Koch MW, Patten S, Berzins S, Zhornitsky S, Greenfield J, Wall W, Metz LM.

Mult Scler. 2015 Jan;21(1):76-82. doi: 10.1177/1352458514536086. Epub 2014 May 22.

PMID:
24852924
15.

Hand dexterity and direct disease related cost in multiple sclerosis.

Koch MW, Murray TJ, Fisk J, Greenfield J, Bhan V, Jacobs P, Brown M, Metz LM.

J Neurol Sci. 2014 Jun 15;341(1-2):51-4. doi: 10.1016/j.jns.2014.03.047. Epub 2014 Apr 2.

PMID:
24768310
16.

Syndrome of inappropriate antidiuretic hormone secretion in a cat with a putative Rathke's cleft cyst.

DeMonaco SM, Koch MW, Southard TL.

J Feline Med Surg. 2014 Dec;16(12):1010-5. doi: 10.1177/1098612X14528192. Epub 2014 Mar 21.

PMID:
24657877
17.

MS incidence and prevalence in Africa, Asia, Australia and New Zealand: A systematic review.

Makhani N, Morrow SA, Fisk J, Evans C, Beland SG, Kulaga S, Kingwell E, Marriott JJ, Dykeman J, Jetté N, Pringsheim T, Wolfson C, Marrie RA, Koch MW.

Mult Scler Relat Disord. 2014 Jan;3(1):48-60. doi: 10.1016/j.msard.2013.06.015. Epub 2013 Jul 25.

PMID:
25877973
18.

Incidence and prevalence of multiple sclerosis in Europe: a systematic review.

Kingwell E, Marriott JJ, Jetté N, Pringsheim T, Makhani N, Morrow SA, Fisk JD, Evans C, Béland SG, Kulaga S, Dykeman J, Wolfson C, Koch MW, Marrie RA.

BMC Neurol. 2013 Sep 26;13:128. doi: 10.1186/1471-2377-13-128. Review.

19.

Treatment trials in progressive MS--current challenges and future directions.

Koch MW, Cutter G, Stys PK, Yong VW, Metz LM.

Nat Rev Neurol. 2013 Sep;9(9):496-503. doi: 10.1038/nrneurol.2013.148. Epub 2013 Jul 30. Review.

PMID:
23897406
20.

Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair.

Zhornitsky S, Wee Yong V, Koch MW, Mackie A, Potvin S, Patten SB, Metz LM.

CNS Neurosci Ther. 2013 Oct;19(10):737-44. doi: 10.1111/cns.12154. Epub 2013 Jul 22. Review.

PMID:
23870612
21.

Performance on Paced Auditory Serial Addition Test and cerebral blood flow in multiple sclerosis.

D'haeseleer M, Steen C, Hoogduin JM, van Osch MJ, Fierens Y, Cambron M, Koch MW, De Keyser J.

Acta Neurol Scand. 2013 Nov;128(5):e26-9. doi: 10.1111/ane.12129. Epub 2013 Apr 1.

PMID:
23550954
22.

Cerebral white matter blood flow and energy metabolism in multiple sclerosis.

Steen C, D'haeseleer M, Hoogduin JM, Fierens Y, Cambron M, Mostert JP, Heersema DJ, Koch MW, De Keyser J.

Mult Scler. 2013 Sep;19(10):1282-9. doi: 10.1177/1352458513477228. Epub 2013 Feb 21.

PMID:
23428956
23.

Epigenetic changes in patients with multiple sclerosis.

Koch MW, Metz LM, Kovalchuk O.

Nat Rev Neurol. 2013 Jan;9(1):35-43. doi: 10.1038/nrneurol.2012.226. Epub 2012 Nov 20. Review.

PMID:
23165337
24.

Environmental factors and their regulation of immunity in multiple sclerosis.

Koch MW, Metz LM, Agrawal SM, Yong VW.

J Neurol Sci. 2013 Jan 15;324(1-2):10-6. doi: 10.1016/j.jns.2012.10.021. Epub 2012 Nov 13. Review.

PMID:
23154080
25.

Epigenetics and miRNAs in the diagnosis and treatment of multiple sclerosis.

Koch MW, Metz LM, Kovalchuk O.

Trends Mol Med. 2013 Jan;19(1):23-30. doi: 10.1016/j.molmed.2012.10.008. Epub 2012 Nov 12. Review.

PMID:
23153574
26.

Multifocal oligodendroglioma in three dogs.

Koch MW, Sánchez MD, Long S.

J Am Anim Hosp Assoc. 2011 Sep-Oct;47(5):e77-85. doi: 10.5326/JAAHA-MS-5551. Epub 2011 Aug 18.

PMID:
21896836
27.

Pharmacologic treatment of depression in multiple sclerosis.

Koch MW, Glazenborg A, Uyttenboogaart M, Mostert J, De Keyser J.

Cochrane Database Syst Rev. 2011 Feb 16;(2):CD007295. doi: 10.1002/14651858.CD007295.pub2. Review.

PMID:
21328292
28.

T2 lesions and rate of progression of disability in multiple sclerosis.

Mostert JP, Koch MW, Steen C, Heersema DJ, De Groot JC, De Keyser J.

Eur J Neurol. 2010 Dec;17(12):1471-5. doi: 10.1111/j.1468-1331.2010.03093.x.

PMID:
20500805
29.

Oxcarbazepine versus carbamazepine monotherapy for partial onset seizures.

Koch MW, Polman SK.

Cochrane Database Syst Rev. 2009 Oct 7;(4):CD006453. doi: 10.1002/14651858.CD006453.pub2. Review.

PMID:
19821367
30.

Treatment of seizures in multiple sclerosis.

Koch MW, Polman SK, Uyttenboogaart M, De Keyser J.

Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007150. doi: 10.1002/14651858.CD007150.pub2. Review.

PMID:
19588420
31.

Does smoking influence outcome after intravenous thrombolysis for acute ischaemic stroke?

Aries MJ, Uyttenboogaart M, Koch MW, Langedijk M, Vroomen PC, Luijckx GJ, De Keyser J.

Eur J Neurol. 2009 Jul;16(7):819-22. doi: 10.1111/j.1468-1331.2009.02596.x. Epub 2009 Mar 26.

PMID:
19473358
32.

Hypoperfusion of the cerebral white matter in multiple sclerosis: possible mechanisms and pathophysiological significance.

De Keyser J, Steen C, Mostert JP, Koch MW.

J Cereb Blood Flow Metab. 2008 Oct;28(10):1645-51. doi: 10.1038/jcbfm.2008.72. Epub 2008 Jul 2. Review.

PMID:
18594554
33.

Therapeutic potential of fluoxetine in neurological disorders.

Mostert JP, Koch MW, Heerings M, Heersema DJ, De Keyser J.

CNS Neurosci Ther. 2008 Summer;14(2):153-64. doi: 10.1111/j.1527-3458.2008.00040.x. Review.

PMID:
18482027
34.

Reproducibility over a 1-month period of 1H-MR spectroscopic imaging NAA/Cr ratios in clinically stable multiple sclerosis patients.

Mostert JP, Blaauw Y, Koch MW, Kuiper AJ, Hoogduin JM, De Keyser J.

Eur Radiol. 2008 Aug;18(8):1736-40. doi: 10.1007/s00330-008-0925-x. Epub 2008 Apr 4.

35.

Lipid profile, statin use, and outcome after intravenous thrombolysis for acute ischaemic stroke.

Uyttenboogaart M, Koch MW, Koopman K, Vroomen PC, Luijckx GJ, De Keyser J.

J Neurol. 2008 Jun;255(6):875-80. doi: 10.1007/s00415-008-0797-7. Epub 2008 Mar 14.

PMID:
18338194
36.

Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke.

Uyttenboogaart M, Koch MW, Koopman K, Vroomen PC, De Keyser J, Luijckx GJ.

Arch Neurol. 2008 May;65(5):607-11. doi: 10.1001/archneur.65.5.noc70077. Epub 2008 Mar 10.

PMID:
18332238
37.

Relationship between the extent of T2 lesions and the onset of secondary progression in multiple sclerosis.

Mostert JP, de Groot JC, Ramsaransing GS, Koch MW, De Keyser J.

Eur J Neurol. 2007 Nov;14(11):1210-5.

PMID:
17956444
38.

Dysfunctional astrocytes as key players in the pathogenesis of central nervous system disorders.

De Keyser J, Mostert JP, Koch MW.

J Neurol Sci. 2008 Apr 15;267(1-2):3-16. Epub 2007 Nov 1. Review.

PMID:
17935736
39.

Moderate hyperglycaemia is associated with favourable outcome in acute lacunar stroke.

Uyttenboogaart M, Koch MW, Stewart RE, Vroomen PC, Luijckx GJ, De Keyser J.

Brain. 2007 Jun;130(Pt 6):1626-30.

PMID:
17525141
40.

Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes.

Koch MW, Mostert JP, de Vries JJ, De Keyser J.

Neurology. 2007 Apr 3;68(14):1163; author reply 1163-4. No abstract available.

PMID:
17404207
41.

Paroxysmal focal dystonia with sensory symptoms secondary to cortical oligoastrocytoma.

Koch MW, Luijckx GJ, Leenders KL.

J Neurol. 2006 Sep;253(9):1227-8. Epub 2006 Apr 5. No abstract available.

PMID:
16598615
42.

Neuroprotection in acute ischemic stroke.

De Keyser J, Uyttenboogaart M, Koch MW, Elting JW, Sulter G, Vroomen PC, Luijckx GJ.

Acta Neurol Belg. 2005 Sep;105(3):144-8. Review.

PMID:
16255152
43.

Indications for and outcome of positive-pressure ventilation in cats: 53 cases (1993-2002).

Lee JA, Drobatz KJ, Koch MW, King LG.

J Am Vet Med Assoc. 2005 Mar 15;226(6):924-31.

PMID:
15786995
44.

Acculturation and mental health--empirical verification of J.W. Berry's model of acculturative stress.

Koch MW, Bjerregaard P, Curtis C.

Int J Circumpolar Health. 2004;63 Suppl 2:371-6.

PMID:
15736688
45.

Taking care of ourselves: healthy communities.

Koch MW.

Tenn Nurse. 1998 Apr;61(2):13-4. No abstract available.

PMID:
10603900
46.

Going home: transition strategies for professional practice in home care and hospice.

Koch MW.

Tenn Nurse. 1995 Dec;58(6):13-5. No abstract available.

PMID:
8695613
47.

Using polygons to recognize and locate partially occluded objects.

Koch MW, Kashyap RL.

IEEE Trans Pattern Anal Mach Intell. 1987 Apr;9(4):483-94.

PMID:
21869406
48.

La colecistografäa en individuos normales.

ZARATE VE, KOCH MW.

Rev Med Valparaiso. 1948 May;1(2):41-5. Undetermined Language. No abstract available.

PMID:
18877822

Supplemental Content

Support Center